Indian Pediatrics

, Volume 48, Issue 7, pp 531–536 | Cite as

Treating hyperglycemia in the critically ill child: Is there enough evidence?

Review Article

Abstract

Need and purpose of review

Hyperglycemia is prevalent among critically ill pediatric patients. Previously thought to be an adaptive response to stress, hyperglycemia is now recognized to be associated with an adverse outcome. Correction of such hyperglycemia with insulin infusion has been shown to improve outcome but carries risk of hypoglycemia. This review addresses these issues related to treatment of hyperglycemia.

Methods

A Pubmed search was performed using the search strategy: (hyperglycemia OR blood glucose OR insulin therapy) AND (critical illness OR critical care OR intensive care unit). Randomized controlled trials, clinical trials, meta-analysis and observational studies (adult and pediatric) published in the last 10 years were included.

Conclusion

Blood sugar monitoring and correction of hyperglycemia while caring for critically ill children is crucial. A modest blood glucose target of <150 mg/dL is appropriate. Providing adequate nutrition along with training of the nursing personnel would prevent any adverse effect such as hypoglycemia.

Key words

Critical illness Hyperglycemia Glucose Insulin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Supplementary material

13312_2011_95_MOESM1_ESM.pdf (40 kb)
Supplementary material, approximately 40 KB.

References

  1. 1.
    Corstjens AM, Van der Horst ICC, Zijlstra JG, Johan Groeneveld AB, Zijlstra F, Tulleken JE, et al. Hyperglycemia in critically ill patients: marker or mediator of mortality? Crit Care. 2006;10:216.PubMedCrossRefGoogle Scholar
  2. 2.
    Marik PE, Raghavan M. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med. 2004;30:748–756.PubMedCrossRefGoogle Scholar
  3. 3.
    Derde S, Vanhorebeek I, Van den Berghe G. Insulin treatment in intensive care patients. Horm Res. 2009;71:2–11.PubMedCrossRefGoogle Scholar
  4. 4.
    Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773–778.PubMedCrossRefGoogle Scholar
  5. 5.
    Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32:2426–2432.PubMedCrossRefGoogle Scholar
  6. 6.
    Sung J, Bochicchio GV, Joshi M, Bochicchio K, Tracy K, Scalea TM. Admission hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma. 2005;59:80–83.PubMedCrossRefGoogle Scholar
  7. 7.
    Srinivasan V, Spinella PC, Drott HR, Roth CL, Helfaer MA, Nadkarni V. Association of timing, duration and intensity of hyperglycemia with intensive care unit mortality in critically ill children. Pediatr Crit Care Med. 2004; 5:329–336.PubMedCrossRefGoogle Scholar
  8. 8.
    Van den Berghe G, Woulters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill. N Engl J Med. 2001;345:1359–1367.PubMedCrossRefGoogle Scholar
  9. 9.
    Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004;79:992–1000.PubMedCrossRefGoogle Scholar
  10. 10.
    Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006; 354: 449–461.PubMedCrossRefGoogle Scholar
  11. 11.
    Treggiari MM, Karir V, Yanez ND, Weiss NS, Daniel S, Deem SA. Intensive insulin therapy and mortality in critically ill patients. Crit Care. 2008;12: R29.PubMedCrossRefGoogle Scholar
  12. 12.
    Wang LC, Lei S, Wu YC, Wu JN, Wang LF, Guan TR, et al. Intensive insulin therapy in critically ill patients. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2006; 18:748–750.PubMedGoogle Scholar
  13. 13.
    Arabi YM, Dabbagh OC, Tamim HM, Al-Shimemeri, Memish ZA, Haddad SH, et al. Intensive versus conventional insulin therapy: A randomised controlled trial in medical and surgical critically ill patients. Crit Care Med. 2008; 36:3190–3197.PubMedCrossRefGoogle Scholar
  14. 14.
    Brunkhorst FM, Engel C, Bloos F, Meier-Hellman A, Ragaller M, Weiler N, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125–139.PubMedCrossRefGoogle Scholar
  15. 15.
    Devos P, Preiser JC, Melot C. Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycemia: final results of the Glucontrol. Intensive Care Med. 2007;33:(Suppl 2):S189.Google Scholar
  16. 16.
    Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: A meta analysis. JAMA. 2008;300:933–944.PubMedCrossRefGoogle Scholar
  17. 17.
    The NICE-SUGAR study investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283–1297.CrossRefGoogle Scholar
  18. 18.
    Griesdale DEG, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009; 180:821–827.PubMedCrossRefGoogle Scholar
  19. 19.
    Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology. 2006;105:244–252.PubMedCrossRefGoogle Scholar
  20. 20.
    Ali NA, O’Brien JM, Jr., Dungan K, Phillips G, Marsh CB, Lemeshow S, et al. Glucose variability and mortality in patients with sepsis. Crit Care Med. 2008; 36:2316–2321.PubMedCrossRefGoogle Scholar
  21. 21.
    Bagshaw SM, Bellomo R, Jacka MJ, Egi M, Hart GK, George C. The impact of early hypoglycemia and blood glucose variability on outcome in critical illness. Crit Care. 2009;13:R91.PubMedCrossRefGoogle Scholar
  22. 22.
    Hermanides J, Vriesendorp TM, Bosman RJ, Zandstra DF, Hoekstra JB, Devries JH. Glucose variability is associated with intensive care unit mortality. Crit Care Med. 2010;38:838–842.PubMedCrossRefGoogle Scholar
  23. 23.
    Faustino EV, Apkon M. Persistent hyperglycemia in critically ill children. J Pediatr. 2005;146:30–34.PubMedCrossRefGoogle Scholar
  24. 24.
    Branco RDG, Tasker RC. Glycemic level in mechanically ventilated children with bronchiolitis. Pediatr Crit Care Med. 2007;8:546–550.PubMedCrossRefGoogle Scholar
  25. 25.
    Day KM, Haub N, Betts H, Inwald DP. Hyperglycemia is associated with morbidity in critically ill children with meningococcal sepsis. Pediatr Crit Care Med. 2008;9:636–640.PubMedCrossRefGoogle Scholar
  26. 26.
    Branco RG, Garcia PCR, Piva JP, Casartelli CH, Seibel V, Tasker RC. Glucose level and risk of mortality in pediatric septic shock. Pediatr Crit Care Med. 2005;6:470–472.PubMedCrossRefGoogle Scholar
  27. 27.
    Wintergrest KA, Buckingham B, Gandrud L, Wong BJ, Kache S, Wilson DM. Association of hyperglycemia, hypoglycemia and glucose variability with morbidity and death in the paediatric intensive care unit. Pediatrics. 2006;118:173–179.CrossRefGoogle Scholar
  28. 28.
    Hirshberg E, Larsen G, van Duker H. Alterations in glucose homeostasis in the pediatric intensive care unit: Hyperglycemia and glucose variability are associated with increased mortality and morbidity. Pediatr Crit Care Med. 2008; 9:361–366.PubMedCrossRefGoogle Scholar
  29. 29.
    Nayak P, Lang H, Parslow RC, Morris K. Hyperglycemia and insulin therapy in the critically ill child. Pediatr Crit Care Med. 2009;10:303–305.PubMedCrossRefGoogle Scholar
  30. 30.
    Yung M, Wilkins B, Norton L, Slater A. Glucose control, organ failure, and mortality in pediatric intensive care. Pediatr Crit Care Med. 2008;9:147–152.PubMedCrossRefGoogle Scholar
  31. 31.
    Preissig CM, Hansen I, Roerig PL, Rigby MR. A protocolized approach to identify and manage hyperglycemia in a pediatric critical care unit. Pediatr Crit Care Med. 2008;9:581–588.PubMedCrossRefGoogle Scholar
  32. 32.
    Vlasselaers D, Milants I, Desmet L, Wouters PJ, Vanhorebeek I, van den Heuvel I, et al. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomized controlled study. Lancet. 2009;373:547–556.PubMedCrossRefGoogle Scholar
  33. 33.
    Maintaining normal blood sugar levels in children undergoing heart surgery to reduce the risk of infections and improve recovery (The SPECS study). http://clinicaltrials.gov/ct2/show/NCT00443599. Accessed October 10, 2010.
  34. 34.
    Macrae D, Pappachan J, Grieve R, Parslow R, Nadel S, Schindler M, et al. Control of hyperglycemia in paediatric intensive care (CHiP): study protocol. BMC Paediatrics. 2010;10:5.CrossRefGoogle Scholar
  35. 35.
    Pediatric ICUs at Emory-Children’s Centre Glycemic Control: The PedETrol Trial. http://clinicaltrials.gov/ct2/show/NCT01116752. Accessed October 10, 2010.
  36. 36.
    Chwals WJ. Hyperglycemia management strategy in the pediatric intensive care setting. Pediatr Crit Care Med. 2008;9:656–658.PubMedCrossRefGoogle Scholar
  37. 37.
    Vincent J. Blood glucose control in 2010. 110 to 150 mg/dL and minimal variability. Crit Care Med. 2010;38:993–995.PubMedCrossRefGoogle Scholar
  38. 38.
    Jeschke MG, Kraft R, Emdad F, Kulp GA, Williams FN, Herndon DN. Glucose control in severely thermally injured pediatric patients: what glucose range should be the target? Ann Surg. 2010;252:521–527.PubMedGoogle Scholar

Copyright information

© Indian Academy of Pediatrics 2011

Authors and Affiliations

  1. 1.Department of Critical Care MedicineSanjay Gandhi Postgraduate Institute of Medical SciencesLucknowIndia

Personalised recommendations